Cost-Effectiveness Evaluation of Enzalutamide and Abiraterone for the Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel in the Mexican Public Healthcare System
May 1, 2018, 00:00
10.1016/j.jval.2018.04.188
https://www.valueinhealthjournal.com/article/S1098-3015(18)30488-1/fulltext
Title :
Cost-Effectiveness Evaluation of Enzalutamide and Abiraterone for the Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel in the Mexican Public Healthcare System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30488-1&doi=10.1016/j.jval.2018.04.188
First page :
Section Title :
Open access? :
No
Section Order :
1029